Major gaps in understanding and treatment of hidradenitis suppurativa
Recommended Citation
Hoffman LK, Ghias MH, Garg A, Hamzavi IH, Alavi A, Lowes MA. Major gaps in understanding and treatment of hidradenitis suppurativa. Seminars in cutaneous medicine and surgery 2017; 36(2):86-92.
Document Type
Article
Publication Date
6-1-2017
Publication Title
Seminars in cutaneous medicine and surgery
Abstract
Hidradenitis suppurativa (HS) is a complex dermatological disease characterized by recurrent painful nodules and suppuration in areas such as the axilla and groin. The disease is poorly understood and treatment is not satisfactory. In October 2016, the Canadian and United States Hidradenitis Suppurativa Foundations organized the inaugural Symposium on Hidradenitis Suppurativa Advances (SHSA) in Toronto, Canada. This meeting brought together experts from Canada, the United States, and Europe to discuss the latest advances in HS. After this important event, we considered that it would be helpful to outline current HS knowledge and to identify important gaps in treatment and research in order to move forward more efficiently. This paper briefly summarizes current knowledge in key areas including epidemiology, clinical presentation and morphological classification, natural history and prognosis, genotype-phenotype correlations, clinico-pathological correlation, pathogenesis, optimal treatment and outcome measures. General and initial suggestions for addressing these gaps are presented.
Medical Subject Headings
Biomedical Research; Hidradenitis Suppurativa; Humans
PubMed ID
28538750
Volume
36
Issue
2
First Page
86
Last Page
92